Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completed

Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity

NCT03342586
completed

A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients

NCT02354378
completednot_applicable

A Pilot Study to Assess the Amnesic Properties of Propofol in Pediatric Patients

NCT02278003
completednot_applicable

Multisensorial Information's Treatment in Autism Spectrum Disorder

NCT02579109

Clinical Trials (4)

Showing 4 of 4 trials
NCT03342586

Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity

Completed
NCT02354378

A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients

Completed
NCT02278003Not Applicable

A Pilot Study to Assess the Amnesic Properties of Propofol in Pediatric Patients

Completed
NCT02579109Not Applicable

Multisensorial Information's Treatment in Autism Spectrum Disorder

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4